Harvard Bioscience SG&A Expense (Quarterly) Insights

Harvard Bioscience Inc (HBIO)

3.69 -0.03 (-0.81%) USD | NASDAQ | Apr 24, 16:00

3.69 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2001. Upgrade now.

Date	Value
December 31, 2023	11.51M
September 30, 2023	11.54M
June 30, 2023	11.53M
March 31, 2023	12.31M
December 31, 2022	11.81M
September 30, 2022	12.14M
June 30, 2022	12.57M
March 31, 2022	13.01M
December 31, 2021	13.46M
September 30, 2021	11.64M
June 30, 2021	12.13M
March 31, 2021	11.72M
December 31, 2020	11.15M
September 30, 2020	9.987M
June 30, 2020	9.949M
March 31, 2020	12.34M
December 31, 2019	11.44M
September 30, 2019	11.90M
June 30, 2019	10.58M
March 31, 2019	12.11M
December 31, 2018	12.55M
September 30, 2018	10.68M
June 30, 2018	11.57M
March 31, 2018	11.03M
December 31, 2017	8.725M

Date	Value
September 30, 2017	7.952M
June 30, 2017	7.664M
March 31, 2017	8.266M
December 31, 2016	10.26M
September 30, 2016	9.789M
June 30, 2016	10.32M
March 31, 2016	11.05M
December 31, 2015	10.30M
September 30, 2015	10.03M
June 30, 2015	10.05M
March 31, 2015	10.03M
December 31, 2014	9.571M
September 30, 2014	8.243M
June 30, 2014	8.554M
March 31, 2014	8.683M
December 31, 2013	9.144M
September 30, 2013	9.088M
June 30, 2013	9.768M
March 31, 2013	9.264M
December 31, 2012	8.329M
September 30, 2012	9.502M
June 30, 2012	9.645M
March 31, 2012	9.629M
December 31, 2011	8.769M
September 30, 2011	8.921M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

9.949M

Minimum

Jun 2020

13.46M

Maximum

Dec 2021

11.72M

Average

11.72M

Median

Mar 2021

SG&A Expense (Quarterly) Benchmarks